Clinical Trial Update: Oslo Antioxidant Study [Phase 1, Phase 2]

View source ↗

Summary

The Oslo Antioxidant Study, a Phase 1/Phase 2 trial sponsored by the University of Oslo, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: University of Oslo | Conditions: Cardiovascular Disease | Phase 1, Phase 2 | Status: COMPLETED